0001607700-15-000001.txt : 20150519 0001607700-15-000001.hdr.sgml : 20150519 20150519124552 ACCESSION NUMBER: 0001607700-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150519 DATE AS OF CHANGE: 20150519 EFFECTIVENESS DATE: 20150519 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KPI Therapeutics, Inc. CENTRAL INDEX KEY: 0001607700 IRS NUMBER: 300786656 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-240176 FILM NUMBER: 15875713 BUSINESS ADDRESS: STREET 1: 219 TERRY AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-378-0400 MAIL ADDRESS: STREET 1: 219 TERRY AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 FORMER COMPANY: FORMER CONFORMED NAME: Kineta Prime Inc. DATE OF NAME CHANGE: 20140509 D 1 primary_doc.xml X0707 D LIVE 0001607700 KPI Therapeutics, Inc. 219 TERRY AVENUE NORTH, SUITE 300 SEATTLE WA WASHINGTON 98109 206-378-0400 DELAWARE Kineta Prime Inc. Corporation true 2013 Charles L. Magness 219 Terry Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Executive Officer Director Biotechnology Decline to Disclose 06b false 2015-05-06 false true false 10000 7000000 27000 6973000 false 2 0 0 0 false KPI Therapeutics, Inc. /Charles L. Magness/ Charles L. Magness President & CEO 2015-05-19